{"id":"https://openalex.org/W1592051994","doi":"https://doi.org/10.1002/9781444346343.ch6","title":"Pharmacology and Mechanisms of Action of Antiviral Drugs: Polymerase Inhibitors","display_name":"Pharmacology and Mechanisms of Action of Antiviral Drugs: Polymerase Inhibitors","publication_year":2011,"publication_date":"2011-11-03","ids":{"openalex":"https://openalex.org/W1592051994","doi":"https://doi.org/10.1002/9781444346343.ch6","mag":"1592051994"},"language":"en","primary_location":{"id":"doi:10.1002/9781444346343.ch6","doi":"https://doi.org/10.1002/9781444346343.ch6","is_oa":false,"landing_page_url":"https://doi.org/10.1002/9781444346343.ch6","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Advanced Therapy for Hepatitis C","raw_type":"other"},"volume":{"id":"https://openalex.org/W2476746833","display_name":"Advanced Therapy for Hepatitis C"},"type":"other","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5008713330","display_name":"Lotte Coelmont","orcid":"https://orcid.org/0000-0002-7888-4534","observed_orcids":["https://orcid.org/0000-0002-7888-4534"]},"institutions":[{"id":"https://openalex.org/I24156275","display_name":"Rega Institute for Medical Research","ror":"https://ror.org/03w5j8p12","country_code":"BE","type":"facility","lineage":["https://openalex.org/I24156275"]},{"id":"https://openalex.org/I99464096","display_name":"KU Leuven","ror":"https://ror.org/05f950310","country_code":"BE","type":"education","lineage":["https://openalex.org/I99464096"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Lotte Coelmont","raw_affiliation_strings":["Laboratory of Virology and Chemotherapy, Rega Institute for Medical Research, University of Leuven, Leuven, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Virology and Chemotherapy, Rega Institute for Medical Research, University of Leuven, Leuven, Belgium","institution_ids":["https://openalex.org/I24156275","https://openalex.org/I99464096"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044261377","display_name":"Leen Delang","orcid":"https://orcid.org/0000-0002-8874-675X","observed_orcids":["https://orcid.org/0000-0002-8874-675X"]},"institutions":[{"id":"https://openalex.org/I24156275","display_name":"Rega Institute for Medical Research","ror":"https://ror.org/03w5j8p12","country_code":"BE","type":"facility","lineage":["https://openalex.org/I24156275"]},{"id":"https://openalex.org/I99464096","display_name":"KU Leuven","ror":"https://ror.org/05f950310","country_code":"BE","type":"education","lineage":["https://openalex.org/I99464096"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Leen Delang","raw_affiliation_strings":["Laboratory of Virology and Chemotherapy, Rega Institute for Medical Research, University of Leuven, Leuven, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Virology and Chemotherapy, Rega Institute for Medical Research, University of Leuven, Leuven, Belgium","institution_ids":["https://openalex.org/I24156275","https://openalex.org/I99464096"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009035731","display_name":"Matheus Froeyen","orcid":"https://orcid.org/0000-0002-8675-6540","observed_orcids":["https://orcid.org/0000-0002-8675-6540"]},"institutions":[{"id":"https://openalex.org/I24156275","display_name":"Rega Institute for Medical Research","ror":"https://ror.org/03w5j8p12","country_code":"BE","type":"facility","lineage":["https://openalex.org/I24156275"]},{"id":"https://openalex.org/I99464096","display_name":"KU Leuven","ror":"https://ror.org/05f950310","country_code":"BE","type":"education","lineage":["https://openalex.org/I99464096"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Mathy Froeyen","raw_affiliation_strings":["Laboratory of Medicinal Chemistry, Rega Institute for Medical Research, University of Leuven, Leuven, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Medicinal Chemistry, Rega Institute for Medical Research, University of Leuven, Leuven, Belgium","institution_ids":["https://openalex.org/I24156275","https://openalex.org/I99464096"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020989565","display_name":"Piet A. Herdewijn","orcid":"https://orcid.org/0000-0003-3589-8503","observed_orcids":["https://orcid.org/0000-0003-3589-8503"]},"institutions":[{"id":"https://openalex.org/I24156275","display_name":"Rega Institute for Medical Research","ror":"https://ror.org/03w5j8p12","country_code":"BE","type":"facility","lineage":["https://openalex.org/I24156275"]},{"id":"https://openalex.org/I99464096","display_name":"KU Leuven","ror":"https://ror.org/05f950310","country_code":"BE","type":"education","lineage":["https://openalex.org/I99464096"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Piet Herdewijn","raw_affiliation_strings":["Laboratory of Medicinal Chemistry, Rega Institute for Medical Research, University of Leuven, Leuven, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Medicinal Chemistry, Rega Institute for Medical Research, University of Leuven, Leuven, Belgium","institution_ids":["https://openalex.org/I24156275","https://openalex.org/I99464096"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5089010495","display_name":"Johan H. Neyts","orcid":"https://orcid.org/0000-0002-0033-7514","observed_orcids":["https://orcid.org/0000-0002-0033-7514"]},"institutions":[{"id":"https://openalex.org/I24156275","display_name":"Rega Institute for Medical Research","ror":"https://ror.org/03w5j8p12","country_code":"BE","type":"facility","lineage":["https://openalex.org/I24156275"]},{"id":"https://openalex.org/I99464096","display_name":"KU Leuven","ror":"https://ror.org/05f950310","country_code":"BE","type":"education","lineage":["https://openalex.org/I99464096"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Johan Neyts","raw_affiliation_strings":["Laboratory of Virology and Chemotherapy, Rega Institute for Medical Research, University of Leuven, Leuven, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Virology and Chemotherapy, Rega Institute for Medical Research, University of Leuven, Leuven, Belgium","institution_ids":["https://openalex.org/I24156275","https://openalex.org/I99464096"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"43","last_page":"52"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10151","display_name":"Hepatitis C virus research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10151","display_name":"Hepatitis C virus research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11495","display_name":"Animal Virus Infections Studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1103","display_name":"Animal Science and Zoology"},"field":{"id":"https://openalex.org/fields/11","display_name":"Agricultural and Biological Sciences"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hepatitis-c-virus","display_name":"hepatitis C virus","score":0.8309999704360962},{"id":"https://openalex.org/keywords/ns5b-rna-dependent-rna-polymerase","display_name":"NS5B RNA-dependent RNA polymerase","score":0.9750000238418579},{"id":"https://openalex.org/keywords/polymerase-inhibitors","display_name":"polymerase inhibitors","score":0.8980000019073486},{"id":"https://openalex.org/keywords/non-nucleoside-inhibitors","display_name":"non-nucleoside inhibitors","score":0.9909999966621399},{"id":"https://openalex.org/keywords/allosteric-inhibition","display_name":"allosteric inhibition","score":0.8980000019073486},{"id":"https://openalex.org/keywords/antiviral-resistance","display_name":"antiviral resistance","score":0.7319999933242798},{"id":"https://openalex.org/keywords/mechanism-of-action","display_name":"mechanism of action","score":0.6340000033378601},{"id":"https://openalex.org/keywords/ns3-4a-protease-inhibitors","display_name":"NS3/4A protease inhibitors","score":0.8600000143051147}],"concepts":[{"id":"https://openalex.org/C2781426373","wikidata":"https://www.wikidata.org/wiki/Q24766653","display_name":"NS5B","level":5,"score":0.7335017919540405},{"id":"https://openalex.org/C2776449523","wikidata":"https://www.wikidata.org/wiki/Q272631","display_name":"RNA polymerase","level":4,"score":0.7073352336883545},{"id":"https://openalex.org/C82381507","wikidata":"https://www.wikidata.org/wiki/Q416878","display_name":"Polymerase","level":3,"score":0.6903790831565857},{"id":"https://openalex.org/C166342909","wikidata":"https://www.wikidata.org/wiki/Q845326","display_name":"Allosteric regulation","level":3,"score":0.6376510858535767},{"id":"https://openalex.org/C41258723","wikidata":"https://www.wikidata.org/wiki/Q2919111","display_name":"RNA-dependent RNA polymerase","level":4,"score":0.5895945429801941},{"id":"https://openalex.org/C2776543447","wikidata":"https://www.wikidata.org/wiki/Q28734","display_name":"Nucleoside","level":2,"score":0.49661070108413696},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.44962722063064575},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4310036301612854},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.4278582036495209},{"id":"https://openalex.org/C67705224","wikidata":"https://www.wikidata.org/wiki/Q11053","display_name":"RNA","level":3,"score":0.4191073477268219},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4050788879394531},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.2636442184448242},{"id":"https://openalex.org/C2776408679","wikidata":"https://www.wikidata.org/wiki/Q708693","display_name":"Hepatitis C virus","level":3,"score":0.20944124460220337},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.1380508542060852},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.09711122512817383},{"id":"https://openalex.org/C2781463415","wikidata":"https://www.wikidata.org/wiki/Q2082778","display_name":"Hepacivirus","level":4,"score":0.0}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1002/9781444346343.ch6","doi":"https://doi.org/10.1002/9781444346343.ch6","is_oa":false,"landing_page_url":"https://doi.org/10.1002/9781444346343.ch6","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Advanced Therapy for Hepatitis C","raw_type":"other"},{"id":"pmh:oai:lirias2repo.kuleuven.be:123456789/262867","doi":null,"is_oa":false,"landing_page_url":"https://lirias.kuleuven.be/handle/123456789/262867","pdf_url":null,"source":{"id":"https://openalex.org/S7407055369","display_name":"Lirias","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Advanced Therapy for Hepatitis C, (43-52)","raw_type":"info:eu-repo/semantics/bookPart"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.8230999708175659,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":51,"referenced_works":["https://openalex.org/W1965962980","https://openalex.org/W1967930625","https://openalex.org/W1973026159","https://openalex.org/W1974922859","https://openalex.org/W1982977346","https://openalex.org/W1986783319","https://openalex.org/W1987073583","https://openalex.org/W1988807696","https://openalex.org/W1992048113","https://openalex.org/W1994650906","https://openalex.org/W1997131757","https://openalex.org/W1997809789","https://openalex.org/W2010150738","https://openalex.org/W2010546204","https://openalex.org/W2013940465","https://openalex.org/W2016117318","https://openalex.org/W2017624799","https://openalex.org/W2018311444","https://openalex.org/W2026065136","https://openalex.org/W2027480021","https://openalex.org/W2032968790","https://openalex.org/W2033944249","https://openalex.org/W2037686553","https://openalex.org/W2069702488","https://openalex.org/W2088631360","https://openalex.org/W2095103987","https://openalex.org/W2101042294","https://openalex.org/W2103185551","https://openalex.org/W2104866417","https://openalex.org/W2106196384","https://openalex.org/W2108571089","https://openalex.org/W2110397834","https://openalex.org/W2114421863","https://openalex.org/W2116873531","https://openalex.org/W2118227068","https://openalex.org/W2125777755","https://openalex.org/W2129802492","https://openalex.org/W2132629607","https://openalex.org/W2142405932","https://openalex.org/W2149881416","https://openalex.org/W2151338378","https://openalex.org/W2158673018","https://openalex.org/W2162024492","https://openalex.org/W2163645037","https://openalex.org/W2168432020","https://openalex.org/W2168586962","https://openalex.org/W2168912424","https://openalex.org/W2170667448","https://openalex.org/W2171470373","https://openalex.org/W2171945301","https://openalex.org/W2953261181"],"related_works":["https://openalex.org/W3023133083","https://openalex.org/W2039660147","https://openalex.org/W7034761471","https://openalex.org/W2312889526","https://openalex.org/W1997131757","https://openalex.org/W2113534162","https://openalex.org/W1488548748","https://openalex.org/W33238524","https://openalex.org/W2059310707","https://openalex.org/W2026612854"],"abstract_inverted_index":{"The":[0,16,54],"HCV":[1,14],"NS5B":[2],"RNA-dependent":[3],"RNA":[4,103,138],"polymerase":[5,21,79,111],"(RdRp)":[6],"is":[7,24],"an":[8],"excellent":[9],"target":[10],"for":[11,48,134],"inhibition":[12],"of":[13],"replication.":[15],"enzyme":[17],"has":[18],"a":[19,28,130,146],"typical":[20],"structure,":[22],"which":[23],"frequently":[25],"compared":[26],"with":[27,51,69],"right":[29],"hand,":[30],"where":[31,40],"the":[32,36,41,44,49,52,62,70,101,106,125],"palm":[33],"domain":[34,64],"contains":[35],"catalytic":[37],"site":[38],"and":[39,43,65,76,84],"fingers":[42],"thumb":[45,71],"are":[46,56,81],"responsible":[47],"interaction":[50],"RNA.":[53],"fingertips":[55],"two":[57],"loops":[58],"that":[59,66],"extend":[60],"from":[61],"finger":[63],"make":[67],"contact":[68],"domain.":[72],"Both":[73],"nucleoside":[74,141],"(NI)":[75],"non-nucleoside":[77,152],"(NNI)":[78],"inhibitors":[80,117,142],"in":[82,100],"pre-clinical":[83],"clinical":[85],"development.":[86],"NIs":[87],"need":[88],"to":[89,93,97,120,144,149],"be":[90,98],"5\u2032-phosphorylated":[91],"intracellular":[92],"their":[94],"corresponding":[95],"5\u2032-triphosphates":[96],"incorporated":[99],"growing":[102],"chain":[104],"by":[105,118],"RdRp,":[107],"thereby":[108,128],"mimicking":[109],"natural":[110],"substrates.":[112],"NNIs":[113],"act":[114],"as":[115],"allosteric":[116],"binding":[119],"less":[121],"conserved":[122],"sites":[123],"outside":[124],"active":[126],"site,":[127],"preventing":[129],"conformational":[131],"transition":[132],"needed":[133],"(the":[135],"initiation":[136],"of)":[137],"synthesis.":[139],"Overall,":[140],"appear":[143],"have":[145],"higher":[147],"barrier":[148],"resistance":[150],"than":[151],"(and":[153],"NS3/4A":[154],"protease)":[155],"inhibitors.":[156]},"counts_by_year":[],"updated_date":"2026-10-30T12:39:25.321706","created_date":"2016-06-24T00:00:00"}